206 related articles for article (PubMed ID: 26413850)
1. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
Weinberg A; Park JG; Bosch R; Cho A; Livingston E; Aweeka F; Cramer Y; Watts DH; Luque AE; Cohn SE
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):137-45. PubMed ID: 26413850
[TBL] [Abstract][Full Text] [Related]
2. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
3. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.
Watts DH; Park JG; Cohn SE; Yu S; Hitti J; Stek A; Clax PA; Muderspach L; Lertora JJ
Contraception; 2008 Feb; 77(2):84-90. PubMed ID: 18226670
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Mngqibisa R; Kendall MA; Dooley K; Wu XS; Firnhaber C; Mcilleron H; Robinson J; Cramer Y; Rosenkranz SL; Roa J; Coughlin K; Mawlana S; Badal-Faesen S; Schnabel D; Omoz-Oarhe A; Samaneka W; Godfrey C; Cohn SE;
Clin Infect Dis; 2020 Jul; 71(3):517-524. PubMed ID: 31504342
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of regulatory T-cells during pregnancy: effect of HIV infection and correlations with other immune parameters.
Richardson K; Weinberg A
PLoS One; 2011; 6(11):e28172. PubMed ID: 22140535
[TBL] [Abstract][Full Text] [Related]
7. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
[TBL] [Abstract][Full Text] [Related]
8. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
Dragoman MV; Gaffield ME
Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
[TBL] [Abstract][Full Text] [Related]
9. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
Nanda K; Callahan R; Taylor D; Wang M; Agot K; Jenkins D; Van Damme L; Dorflinger L;
Contraception; 2016 Jul; 94(1):40-7. PubMed ID: 26972780
[TBL] [Abstract][Full Text] [Related]
10. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
11. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
12. Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.
Luque AE; Cohn SE; Park JG; Cramer Y; Weinberg A; Livingston E; Klingman KL; Aweeka F; Watts DH
Antimicrob Agents Chemother; 2015 Apr; 59(4):2094-101. PubMed ID: 25624326
[TBL] [Abstract][Full Text] [Related]
13. The impact of short-term depot-medroxyprogesterone acetate treatment on resting metabolic rate.
Steward RG; Bateman LA; Slentz C; Stanczyk FZ; Price TM
Contraception; 2016 Apr; 93(4):317-322. PubMed ID: 26772904
[TBL] [Abstract][Full Text] [Related]
14. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Huijbregts RP; Michel KG; Hel Z
Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
[TBL] [Abstract][Full Text] [Related]
15. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.
Huijbregts RP; Helton ES; Michel KG; Sabbaj S; Richter HE; Goepfert PA; Hel Z
Endocrinology; 2013 Mar; 154(3):1282-95. PubMed ID: 23354099
[TBL] [Abstract][Full Text] [Related]
16. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
[TBL] [Abstract][Full Text] [Related]
17. Differential Elevation of Inflammation and CD4
Omollo K; Lajoie J; Oyugi J; Wessels JM; Mwaengo D; Kimani J; Kaushic C; Fowke KR
Front Immunol; 2020; 11():598307. PubMed ID: 33717049
[TBL] [Abstract][Full Text] [Related]
18. Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate.
Lange HL; Manos BE; Gothard MD; Rogers LK; Bonny AE
J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):169-175. PubMed ID: 27789350
[TBL] [Abstract][Full Text] [Related]
19. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
20. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
